Epidemics Act (EpidA)

By Steph2
12345678910111213141516171819202122
In The Matter OfEpidemics Act (EpidA)
Exhibit A
Scroll to open

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

Art. 71 Costs borne by the cantons

The cantons shall bear the cost of: a. measures in relation to the population or individual persons, insofar as the costs are not otherwise covered; b. epidemiological investigations under Article 15 paragraph 1.

Art. 72 Costs of disinfection or disinfestation

The proprietor of a mode of transport, an installation or a product shall bear the costs of disinfection or disinfestation.

Art. 73 Cost of supplying therapeutic products

1 The Confederation shall bear the cost of supplying the population with therapeutic products pursuant to Article 44. 2 If therapeutic products are supplied, the costs shall be borne according to the requirements: a. of the Federal Act of 18 March 1994 on Health Insurance; b. of the Federal Act of 20 March 1981 on Accident Insurance; c. of the Federal Act of 19 June 1992 on Military Insurance. 3 If the costs are not or not completely assumed in accordance with paragraph 2, they shall be borne by the Confederation.

Para. 2 let. a — SR 832.10 Para. 2 let. b — SR 832.20 Para. 2 let. c — SR 833.1

Art. 74 Costs of international travel measures

1 The Confederation shall bear the cost of testing, monitoring, quarantine, isolation and treatment ordered by its bodies for passengers on international transport services, as well as the costs incurred as a result of the duty to cooperate under Article 43 paragraph 1 letters b, d and e. 2 Companies that transport persons internationally by rail, bus, ship or air, airport operators, port operators, railway stations and bus stations and travel businesses shall bear the costs incurred for preparations made under Article 42 and as a result of the duty to cooperate under Article 43 paragraph 1 letters a and c. The Confederation may contribute to exceptional outlays and expenditures if these place the companies concerned under an unreasonable financial burden.